Company / Interest Expense
NovoCure Ltd Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$22.2M
FY2025
5-year range
$4.9M / $22.2M
FY2021-FY2025
Trend
+90.5%
vs FY2024
Sector context
#30 of 40
Health Care
What the data says
NovoCure Ltd's interest expense of $22M is lower than 75% of companies in the Health Care sector (FY2025). Interest Expense has fluctuated over the past 10 years, ranging from $5M in FY2023 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +4.2%.
Increased from $5M to $22M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +39.9%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 40This company $22.2M Sector average $332.7M
▼
-93.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, interest expense increased 90.5% year-over-year.
- Ranks #30 out of 40 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.2M | +90.5% |
| FY2024 | $11.7M | +137.7% |
| FY2023 | $4.9M | -39.5% |
| FY2022 | $8.1M | -8.2% |
| FY2021 | $8.8M | -51.0% |
| FY2020 | $18.1M | +23.3% |
| FY2019 | $14.6M | -13.4% |
| FY2018 | $16.9M | +44.6% |
| FY2017 | $11.7M | +59.8% |
| FY2016 | $7.3M | +126.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026